Connect with:
Thursday / April 25. 2024

logo
mobile-logo
HomePosts Tagged "Financial results for Q1 FY23"
Agro chems – Chemicals, Agro chems – Fertilizers, Agro chems – Pesticides, Company News, Finance, Inputs, World

The fall in sales is mainly driven by lower volumes and prices for glyphosate-based products in North and Latin America as well as in Europe/Middle East/Africa.

Bayer has published detailed results for the second quarter of 2023, after having already communicated key figures for the three-month period and lowering its outlook for full-year 2023 in a July 24 news release. The revised guidance was mainly due to a significant further decline in sales of glyphosate-based products at the Crop Science Division.

Sales in the agricultural business (Crop Science) fell by 18.5 percent (Fx & portfolio adj.) to 4.924 billion euros, mainly driven by lower volumes and prices for glyphosate-based products. This effect particularly impacted business in North and Latin America as well as in Europe/Middle East/Africa and resulted in a 45.6 percent decrease in sales (Fx & portfolio adj.) at Herbicides. Excluding the glyphosate business, Crop Science sales were level with the previous year (Fx & portfolio adj.), as higher prices were offset by lower volumes. Sales at Corn Seed & Traits rose by 10.6 percent (Fx & portfolio adj.), largely thanks to higher prices in all regions as well as increased acreages in North America. Business at Fungicides was level with the prior-year quarter (Fx & portfolio adj.). Sales at Soybean Seed & Traits were down 9.3 percent (Fx & portfolio adj.), mainly due to decreased acreages and a decline in license revenues in North America.

EBITDA before special items at Crop Science fell by 58.5 percent to 725 million euros, primarily due to the decline in sales of glyphosate-based products. Higher prices in the rest of the business and cost savings only partially compensated for this effect. Earnings were also diminished by a mainly inflation-related increase in the cost of goods sold and a negative currency effect of 96 million euros (Q2 2022: positive currency effect of 215 million euros).

The fall in sales is mainly driven

Agro chems – Chemicals, Company News, Finance, India

 Company’s Profit Before Tax for the quarter stood at Rs 4,061 million, compared to Rs 3,823 million in the corresponding quarter of the previous financial year.

Bayer CropScience Limited announced its unaudited results for the first quarter (Q1) of Financial Year (FY) 2023-24. For Q1 ended June 30, 2023, the Company registered Revenue from Operations of Rs 17,396 million, compared to Rs 16,674 million in the corresponding period of FY 2022-23. Profit Before Tax for the quarter stood at Rs 4,061 million, compared to Rs 3,823 million in the corresponding quarter of the previous financial year.

Commenting on the quarterly results, Simon-Thorsten Wiebusch, Executive Director, Bayer CropScience Limited said, “In Q1 of FY2023-24 despite the impact of delayed monsoon we continued to see strong growth in Sales and liquidation of our Crop Protection portfolio. As expected, we witnessed Roundup™ price normalization impacting the overall Sales growth of the quarter. Corn seeds continue to yield strong results with volume growth driven by portfolio and better acreages in Kharif.”

Simon Britsch, Chief Financial Officer, Bayer CropScience Limited, while speaking about the quarterly results said, “We have delivered modest reported Revenue from Operations growth of 4% for the quarter and adjusted for the effect of customer incentive programs, we delivered a Revenue from Operations growth of 9 per cent for the quarter despite normalization of Roundup™ pricing. We have continued to proactively manage costs and invest in targeted growth opportunities resulting in increased Profit Before Tax by 6 per cent.”

 Company’s Profit Before Tax for the quarter

Agro chems – Chemicals, Agro chems – Fertilizers, Company News, Finance, Middle East countries

Company’s operating income was $465 million versus $902 million, while adjusted operating income was $480 million versus $880 million in the first quarter of last year.

ICL, Israel-based a leading global specialty minerals company, reported its financial results for the first quarter ended March 31, 2023. Consolidated sales were $2.1 billion versus $2.5 billion. Operating income was $465 million versus $902 million, while adjusted operating income was $480 million versus $880 million in the first quarter of last year. Adjusted EBITDA was $610 million versus $1,002 million. Earnings per share were $0.22 versus $0.49, and adjusted diluted EPS was $0.23 versus $0.48.

“ICL delivered another solid first quarter, even as prices pulled back significantly from last year’s peak levels. We are working to leverage opportunities created by geopolitical developments, global sustainability challenges and the current capital markets backdrop, to strengthen long-term value creation through innovative food security and battery materials solutions, while maintaining our focus on consistent cash generation and on driving cost efficiencies,” said Raviv Zoller, president and CEO of ICL. “For the first quarter, we continued to return value to shareholders, as we delivered record operating cash flow of $382 million and announced a dividend of $0.11 per share.”

The company also reiterated its guidance for full year adjusted EBITDA of between $2.2 billion to $2.4 billion, with approximately $1.1 billion of this amount estimated to come from the company’s specialties focused businesses. (1a).

First quarter 2023 summary

  • Sales of $564 million vs. $566 million.
  • EBITDA of $45 million vs. $110 million.
  • Margin decreased, due to destocking during a declining price environment.

Key developments

  • Specialty agriculture: Sales declined versus the prior year, as lower volumes offset higher prices achieved through new product launches.
  • Turf and ornamental: Results softened year-over-year, as higher prices from new product launches were unable to offset weaker ornamental and horticulture sales volumes.
  • Brazil: Sales increased versus the prior year, while profit was impacted by higher-cost inventory.
  • Polysulphate: Sales and profit increased year-over-year, with record production at Boulby of 259,000 metric tons.

Company’s operating income was $465 million versus

Agro chems – Chemicals, Company News, Europe, Finance

The company recorded double-digit percentage gains in the Europe/Middle East/Africa and Asia/Pacific regions, but saw sales fall in Latin and North America, mainly due to lower volumes.

The Bayer Group experienced a slow start to 2023 as expected. “Sales were on a par with the exceptionally strong prior-year quarter,” CEO Werner Baumann said on Thursday when presenting the Quarterly Statement for the first quarter. The normalization in the glyphosate business has accelerated, although this effect was largely offset by growth in the other parts of the Crop Science business, he explained. Group earnings were mainly weighed down by the glyphosate business and inflation, and were also impacted by R&D investment at Pharmaceuticals, which remained high.

In the agricultural business (Crop Science), sales declined by 1.1 percent (Fx & portfolio adj.) to 8.351 billion euros. Excluding the glyphosate business, Crop Science sales were up around 8 percent (Fx & portfolio adj.). The division recorded double-digit percentage gains in the Europe/Middle East/Africa and Asia/Pacific regions, but saw sales fall in Latin and North America, mainly due to lower volumes. Sales at Herbicides decreased by 24.3 percent (Fx & portfolio adj.) due to lower volumes and prices for glyphosate-based products. By contrast, Corn Seed & Traits saw sales rise by a substantial 15.8 percent (Fx & portfolio adj.), primarily driven by higher prices in the North America and Europe/Middle East/Africa regions. Sales at Insecticides rose by 12.6 percent (Fx & portfolio adj.), with significant price and volume increases in Europe/Middle East/Africa thanks to Movento™ and in Latin America due to Curbix™ more than offsetting lower volumes in North America. Sales were also up at Soybean Seed & Traits, which registered growth of 1.4 percent (Fx & portfolio adj.) that was mainly driven by higher volumes in Latin America. Sales at Fungicides came in at the prior-year level, with higher prices in all regions offsetting lower volumes in Latin and North America in particular.

EBITDA before special items at Crop Science decreased by 11.0 percent to 3.267 billion euros, mainly due to the fall in sales in Latin and North America. Earnings were also diminished by an increase in particular in the cost of goods sold, which was due to high inflation. There was a positive currency effect of 54 million euros (Q1 2022: 98 million euros). The EBITDA margin before special items declined by 4.3 percentage points to 39.1 percent.

Baumann confirmed the Group outlook for full-year 2023 based on the average monthly exchange rates from 2022. However, for the remainder of the year Bayer sees potential risks mainly arising from the significantly reduced market price expectations for glyphosate-based products, he said. “We continue to expect performance to improve in our other businesses in the second half of the year,” Baumann noted. “Overall, we expect target attainment to come in at the lower end of our guidance.”

The company recorded double-digit percentage gains in

Agro chems – Chemicals, Agrotech, Company News, Europe, Finance, Seeds

All business units delivered growth except ADAMA which was particularly impacted by lower sales of its non-agricultural businesses in the US and China.

 Switzerland based Syngenta Group announced financial results for the first quarter of 2023. Sales for the first quarter 2023 were $9.2 billion, up $0.3 billion or 3 percent (+8 per cent at CER), compared to a strong first quarter 2022. First quarter 2023 EBITDA increased 1 per cent (+9% at CER) from prior year to $1.9 billion.

All business units continued benefitting from demand for innovative products and services that promote yield increases and support regenerative farming methods that combat climate change, enhance soil health, and preserve biodiversity and water quality.

The Group continued to sustain higher prices to help offset higher costs. Seeds market growth remained robust while the market for crop protection non-selective herbicides has slowed as inventories are reduced through the supply chain.

All business units delivered growth except ADAMA which was particularly impacted by lower sales of its non-agricultural businesses in the US and China. EBITDA margin for the Group was 20.2 per cent. The growth of Syngenta Group’s crop protection businesses was slower compared to the exceptionally strong quarters in the prior two years. Prices were higher versus the prior year, helping offset cost increases. Syngenta Seeds continued its strong momentum and delivered double digit sales growth driven by price increases across all regions that offset higher costs.

Syngenta Group continued its strong growth in China. Syngenta Group China’s MAP sales grew 62 percent to $1.1 billion as the number of MAP centres increased by 124 from a year earlier to a total of 638 centres. Average sales per centre were up 29 per cent year-on-year. With the MAP offering, farmers can modernize farming practices sustainably, while boosting crop quality and farm profitability. The Group’s digital solutions have been adopted on 226 million acres globally with high demand from farmers in key markets.

Syngenta Crop Protection

Syngenta Crop Protection sales grew 2 percent to $4.3 billion in the first quarter 2023. Sales in North America sales grew 22 percent; Europe, Africa and the Middle East grew 1 percent. In Asia Pacific (excluding China), sales were 4 percent lower, reduced by 12 percent adverse currency movements. Sales in Latin America decreased by 17 percent as pre-season channel stocking subsided; and China sales grew by 27 per cent, despite an adverse impact of 11 percent from a stronger US dollar.   Syngenta Crop Protection received regulatory approval for its PLINAZOLIN® technology in five countries including Brazil and India, providing farmers with cutting-edge insect control and addressing urgent resistance challenges.

ADAMA

ADAMA sales were 12 percent lower at $1.6 billion in the first quarter 2023.  Sales in Europe, Africa and the Middle East and Latin America remained flat. North America decreased by 26 percent primarily affected by the consumer and the professional product segments; Asia Pacific (excluding China) decreased 14 percent. Sales in China were 23 percent lower largely due to non-agricultural chemical sales. ADAMA launched Cosayr® and Lapidos®, two Chlorantraniliprole-based insecticides in India, protecting rice and sugar cane crops from pests.

Syngenta Seeds

Syngenta Seeds sales grew 12 percent to $1.5 billion in the first quarter 2023, as price increases covered higher costs. Field crop sales in Europe, Africa and the Middle East grew 21 percent; North America grew 3 percent; Asia Pacific (excluding China) increased 21 percent; and China 41 percent. Latin America was 15 percent lower, constrained by product availability. Sales of Vegetable Seeds decreased by 1 per cent.

All business units delivered growth except ADAMA

Agro chems – Chemicals, Company News, Finance, India

Company has posted total income of Rs 5017.41 crore in Q1 FY23 against total income Rs 2417.24 crores in Q1 FY22 registering a growth of 107.57 per cent.

Rashtriya Chemicals and Fertilizers Limited has reported Consolidated financial results for the period ended June 30, 2022. The company has reported total income of Rs. 5017.41 crores during the period ended June 30, 2022 as compared to Rs. 4140.66 crores during the period ended March 31, 2022. Company has reported 44.40 per cent growth at Rs 299.60 crore in net profit in Q1 FY2023 compared to net profit of Rs 207.48 crore in Q1 FY2022.

The company has posted net profit / (loss) of Rs. 299.60 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 233.84 crores for the period ended March 31, 2022.Comapny has posted total income of Rs 5017.41 crore in Q1 FY23 against total income Rs 2417.24 crores in Q1 FY22 registering a growth of 107.57 per cent.

The company has reported EPS of Rs.5.43 for the period ended June 30, 2022 as compared to Rs.3.76 for the period ended June 30, 2021.

Company has posted total income of Rs

Animal Health, Company News, Finance, India, Live Stock, Poultry

Health Products sales constituted 34 per cent of the total sales in Q1 FY23, versus 20 per cent in Q1 FY22.

One of the India’s leading poultry and animal vaccine manufacturing company, Hester Biosciences Limited has reported consolidated net profit of Rs. 3.56 crore and Revenue from Operations of Rs. 50.70 crore for the Q1FY23. Individually, the gross margins of the vaccines and the health products have been in line with the corresponding quarter, however, the overall margins have reduced due to the increase in the proportion of health products sales which have lower gross margins compared to vaccines. Health Products sales constituted 34 per cent of the total sales in Q1 FY23, versus 20 per cent in Q1 FY22.

Highlights of Q1 FY23

On the vaccine side:

The recent outbreak of Lumpy Skin Disease (LSD) in certain parts of the country since July 2022 is expected to result in additional sales in Q2 FY23.

The Company was a successful bidder in a government tender for PPR vaccine for sheep & goat, the supplies for which are likely to start from September 2022.

Vaccine sales declined by 30 per cent in Q1 FY23 compared to the corresponding quarter, largely due to two reasons:

The comparative period last year had hugely benefited from one-off sales on account of the then prevailing poultry disease outbreak. Our sales were near to a record high due to the outbreaks.

The decline was in the sales of poultry vaccines in Q1 FY23. The poultry industry continued to face strong headwinds on account of increased cost of inputs (mainly feed) and pricing pressure on eggs and broiler birds. Consequent to severe margin pressure, the poultry industry sharply reduced new bird placements along-with initiatives towards input cost optimisation.

Relative increase in marketing expenses in Q1 FY23 as against in Q1 FY22 which were significantly lower due to Covid travel restrictions (notwithstanding the higher sales in Q1 FY22 due to disease situation in poultry)

Increased market development cost in Animal Health and Petcare Divisions on account of company’s continuous efforts in expansion activities. These are expected to moderate over next few quarters as growth in sales picks up in new territories.

Petcare division

The Company launched a new division for Petcare during Q1 with 10 products. Activities related to market development, field force establishment and product pipeline are ongoing. Petcare Division will emerge as a steady long term growth driver, given the increasing adoption of pets in the country.

The Company is strengthening its new product vaccine pipeline by developing new vaccines like Classical Swine Fever (CSF), Sheep Pox and an improved version of Brucella vaccines. Bulk antigen production capacity expansion project is completed and trial runs are ongoing. Expansion of Fill-Finish line capacity is expected to be completed by Q4FY23. These 2 expansions will double the production capacity in vaccines. The recent notification by Government of India to allow the manufacture and sale of Avian Influenza Inactivated vaccine, H9N2 strain, will contribute to our sales from Q3.

Health Products sales constituted 34 per cent

Company News, Finance, India, Sugar industry

Company has registered Rs 2,851 crore net revenue from operations in Q1FY23 compared to Rs 1,957 crore in Q1 FY22.

 DCM Shriram Ltd. announced its Q1 FY23 financial results. Company has reported Rs 2,851 crore net revenue from operations in Q1FY23 compared to Rs 1,957 crore in Q1 FY22 registering 46 per cent growth YoY.

Key developments of Q1 FY23 are as follows.

  • Net Revenues (net of excise duty on sale of country liquor) up 46 per cent YoY at Rs 2,851 crore.
  • Chemicals revenues up by 117 per cent at Rs 896 crore driven by prices & volumes.
  • Vinyl business revenues up 31 per cent at Rs 243 crore driven by volumes and prices.
  • Carbide prices up 18 per cent and PVC prices up 3 per cent.
  • Carbide volumes up 135 per cent. PVC volumes down 13 per cent YoY. Volumes in Q1 FY22 were affected due to second wave of Covid 19. Volumes had an impact of Rs 24 crore on the revenues.
  • Fertilizer revenues up 46 per cent at Rs 321 crore resulting from higher gas prices which is a pass through.
  • Shriram Farm Solutions (SFS) revenues stable at Rs 218 crore vs 212 for Q1 FY22.
  • Overall, Sugar business revenues (net of excise duty on country liquor sales) up 26 per cent at Rs 710 crore led by sugar volumes up 20 per cent YoY, due to better releases and domestic sugar prices up 7 per cent.
  • Distillery volumes up 12 per cent YoY and ethanol prices also higher for current ethanol season
  • Bioseed revenues up 9 per cent YoY at Rs 205 crore
  • Revenue from India operations up 31 per cent YoY led by Cotton in trade channel and Corn in institutional channel.

Commenting on the performance for the quarter and period ending March 2022, in a joint statement, Ajay Shriram, Chairman & Senior Managing Director, and Vikram Shriram, Vice Chairman & Managing Director, said, “We are witnessing very high inflation levels across the globe after many decades. There are supply chain disruptions, prices of key commodities are still elevated, Interest rates are rising, currencies across the globe are at historic lows against the US dollar and there is Russia-Ukraine conflict which is continuing. These have led to uncertain economic environment. With our strong businesses and balance sheet we are well placed to manage these uncertainties. Our operating and financial performance during the quarter continues to remain strong.

Sugar business is facing margin pressures in Sugar; however, Ethanol earnings are stable. This season costs have gone up with increased in SAP as well as adverse climate factors. Sugar policy especially in Uttar Pradesh requires better support from government. Ethanol continues to get fillip from the Government considering their target of 20 per cent mandate by 2025, here again cane juice-based ethanol requires a differentiated policy for UP given unfavourable cost dynamics. Fenesta & Shriram Farm Solutions businesses continue to witness good growth with new product portfolios & geographical expansion.

We are investing close to Rs 3,500 crores in various projects primarily in Chemicals and Sugar business which are to be commissioned over the next 12 months and will be funded from internal accruals and debt. These projects will increase our scale, forward integration, new product lines along with bringing efficiencies and cost reduction. Some of these projects are directed towards creating wealth out of waste, building future capabilities and reducing carbon footprint.

Company has registered Rs 2,851 crore net

Agrotech, Company News, Finance, Sugar industry

Total Income higher by 141%, driven by volume and price growth, with refinery and distillery segments being the major contributors.

Shree Renuka Sugars Limited – one of India’s largest sugar and green energy (ethanol and renewable power) producers and a subsidiary of Wilmar Sugar Holdings Pte Ltd, Singapore – has reported its financial performance for the quarter ended June 30, 2022.

Highlights of the results for the quarter are summarized below.

Total income up by 141 per cent over the previous year from Rs 8,067 Mn to Rs 19,401 million.

 The company posted strong Q1 performance driven by double digit volume growth and higher margins across all its business segments compared to a year ago.

Growth was led by 1) Refinery (175 per cent) & Distillery (89 per cent), 2) Consumer pack sales grew by 4%. Realization remained robust and improved by 5 per cent.

Distillery had a record production of 4.62 crore litres despite being off season due to availability of stored molasses, compared to 1.84 crore litres produced in the previous year.

Atul Chaturvedi, Executive Chairman said, “This quarter’s results must be seen in the light of soaring global inflation, high interest rates, high crude prices and weakening currency. Commodity markets remain very volatile, compelling Government to resort to export restrictions. Our total income for the quarter has increased by 141 per cent over the previous year. Revenues have grown significantly across all segments with better sales realization.

With the onset of good monsoon in the country, we anticipate better sugarcane availability in the upcoming season (October-September) also. Besides improving the balance sheet and cash flows of sugar mills, higher ethanol sales has ensured timely payment of cane dues to farmers and balance out sugar inventories. We remain very optimistic in the financial performance and overall growth of our Company.”

 Sunil Ranka, Chief Financial Officer said, “Shree Renuka Sugars has delivered a strong financial performance in the first quarter with a gross profit growth of about 311 per cent and EBITDA growth of 359 per cent. High volumes and margins propped up EBITDA up to Rs 1,102 Mn from negative Rs 425 Mn in the previous year.

Ethanol blending program has been a game changer for the sugar sector and this has de-risked the seasonal and cyclical nature of business. Good monsoon, strong sugarcane planting and government policies will keep Renuka on the growth path.”

Total Income higher by 141%, driven by

Agrotech, Biofuel industry, Company News, Finance

Income from operations stood at Rs 729.87 crore (Q1 FY22: Rs. 386.26 crore; Q4 FY22: Rs. 829.01 crore)

Pune based Praj Industries (Praj), a globally leading process engineering company with a bouquet of sustainable solutions for Bioenergy, Cleantech and Greentech industry announced its unaudited financial results for the quarter ended June 30, 2022

Performance Review for Q1 FY23 ‐ Consolidated:

Income from operations stood at Rs 729.87 crore (Q1 FY22: Rs. 386.26 crore; Q4 FY22: Rs. 829.01 crore)

PBT is at Rs. 54.23 crore for the period (Q1 FY22: Rs. 29.80 crore; Q4 FY22: Rs. 78.05 crore)

PAT is at Rs. 41.26 crore (Q1 FY22: Rs. 22.20 crore; Q4 FY22: Rs. 57.65)

Order intake during the quarter Rs. 1094 crore (Q1 FY22: Rs. 661 crores; Q4 FY22: Rs. 1101.5 crore)

Commenting on the Company’s performance, Shishir Joshipura, CEO & MD, Praj Industries said, “We have started FY  23 on a strong note with positive developments on order book and delivery volumes. However, challenges around volatile commodity prices, impact of war in Europe and rising global inflation continued. With commodity prices & supply chains stabilizing and increased focus on sustainable energy transition, business environment is expected to be conducive going forward.”

Key Developments:

1.Praj was conferred with the prestigious Fortune India THE NEXT  500 in the Engineering sector. Fortune India Next 500 is a ranking of the top five hundred midsize corporations in India compiled based on the latest sales and gross revenue figures. This award is a recognition of the remarkable growth and outstanding performance among the most promising mid‐sized companies in India.

2.Praj was bestowed with prestigious Golden Peacock Award in the Innovative Product and Service category for its ground‐breaking product BIOSYRUP®.  BIOSYRUP® makes it possible to store sugarcane juice in form of syrup for up to 12 months without any contamination or loss of sugar.

3. Praj joined Mission Possible Partnership (MPP), International Alliance to Pursuit Net Zero Aviation.

Income from operations stood at Rs 729.87

Agro chems – Chemicals, Company News, Finance, India

The company recorded revenue of Rs 463.7 crores in Q1 FY23 as against Rs 344.6 crores in Q1 FY22.

 Best Agrolife Ltd, India’s fastest-growing agrochemical company has reported strong financial results for the first quarter ended 30th June, 2022. It posted a multi-fold jump in its consolidated revenue at Rs 463.7 Crores jumping 49.9 per cent QoQ. The EBITDA stood at Rs 65.9 crores, displaying an 82.7 per cent YoY growth and 6.1 per cent QoQ growth in the first quarter of the current fiscal, the company said in its statement.

Best Agrolife Ltd (BAL), the leading manufacturer of agro-inputs in India. It declared its financial results for Q1FY23 on 05 August 2022 at the meeting of its Board of Directors.

Consolidated Key Highlights-Q1 FY23

▪ The company recorded revenue of Rs 463.7 crores, a growth of 34.6 per cent as against Rs 344.6 crores in Q1 FY22. On a sequential basis, revenue grew by 49.9 per cent.

▪ EBITDA at Rs 65.9 Crores grew significantly by 82.7 per cent as against ₹ 36.06 Crores in Q1 FY22; EBITDA margin for the quarter at 14.2 per cent as against 10.5 per cent in Q1 FY22.

▪ PBT at Rs 53.4 Crores, a growth of 53.5 per cent Y-o-Y & 8.4 per cent on Q-o-Q basis

▪ PAT also registered a robust growth of 54.7 per cent YoY at Rs 40.1 Crores in comparison to Rs 25.94 Crores reported in Q1 FY21.

Commenting on the results, Vimal Alawadhi, Managing Director, BAL, said, “We are pleased to inform you that after closing FY2022 with strong results we have succeeded in maintaining our upward growth momentum in the first quarter of the current fiscal year as well. Due to our futuristic vision, discipline, and carefully crafted strategy we improved on FY22 EBITDA margins despite inflationary pressures. During this quarter we launched many new revolutionary products including our patented product RONFEN. The initial response has been good and we expect a pick-up in the next quarter.”

The company recorded revenue of Rs 463.7

Agro chems – Chemicals, Finance, India

The company has reported total income of Rs 1567.3 crores during the period ended June 30, 2022 as compared to Rs.1221.5 crores during the period ended June 30, 2021.

Agrochemical major PI Industries Limited has reported consolidated financial results for the period ended June 30, 2022. The company has posted total income of Rs 1567.3 crores during the period ended June 30, 2022 as compared to Rs 1415.2 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs 262.4 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs 204.4 crores for the period ended March 31, 2022.The company has reported EPS of Rs. 17.29 for the period ended June 30, 2022 as compared to Rs. 13.48 for the period ended March 31, 2022.

The company has reported total income of Rs. 1567.3 crores during the period ended June 30, 2022 as compared to Rs1221.5 crores during the period ended June 30, 2021.The company has reported EPS of Rs.17.29 for the period ended June 30, 2022 as compared to Rs.12.34 for the period ended June 30, 2021.

The company has reported total income of

Agro chems – Chemicals, Agrotech, Company News, Finance, India

The company has posted net profit / (loss) of Rs 49.1101 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs 54.4026 crores for the period ended March 31, 2022.

Agrochemical major, Dhanuka Agritech Limited has reported total income of Rs. 409.5782 crores during the period ended June 30, 2022 as compared to Rs. 330.4875 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 49.1101 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 54.4026 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 10.54 for the period ended June 30, 2022 as compared to Rs. 11.68 for the period ended March 31, 2022.The company has reported total income of Rs. 409.5782 crores during the period ended June 30, 2022 as compared to Rs.371.5354 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.49.1101 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.48.6007 crores for the period ended June 30, 2021.The company has reported EPS of Rs.10.54 for the period ended June 30, 2022 as compared to Rs.10.43 for the period ended June 30, 2021.

The company has posted net profit /

Agro chems – Chemicals, Company News, Finance

The company has posted net profit / (loss) of Rs.22.6399 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.38.0630 crores for the period ended June 30, 2021.

Sharda Cropchem Limited has reported Consolidated financial results for the period ended June 30, 2022.The company has reported total income of Rs. 844.7811 crores during the period ended June 30, 2022 as compared to Rs 1437.1536 crores during the period ended March 31, 2022.The company has posted net profit / (loss) of Rs. 22.6399 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 176.9742 crores for the period ended March 31, 2022.

Financial Results (Q1 FY2023) – YoY Comparison

The company has reported total income of Rs 844.7811 crores during the period ended June 30, 2022 as compared to Rs 629.1410 crores during the period ended June 30, 2021.The company has posted net profit / (loss) of Rs.22.6399 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.38.0630 crores for the period ended June 30, 2021.

The company has reported EPS of Rs 2.51 for the period ended June 30, 2022 as compared to Rs.4.22 for the period ended June 30, 2021.

The company has posted net profit /